Home Medicine Streptococcus gallolyticus Group Bacteremia and Colonic Adenocarcinoma
Article Open Access

Streptococcus gallolyticus Group Bacteremia and Colonic Adenocarcinoma

  • Agnes McAuliffe , Varun Bhat and Jaclyn Cox
Published/Copyright: January 1, 2019

A 76-year-old woman presented to the emergency department with a fever (38.9°C), vomiting, and diarrhea of 2 days’ duration. The patient's medical history included coronary artery disease, stroke, hypertrophic cardiomyopathy, diastolic heart failure, hypertension, and end-stage renal disease, for which she received dialysis. She had no personal or family history of colon cancer. Blood cultures demonstrated growth of Streptococcus gallolyticus (formerly known as Streptococcus bovis) group bacteremia. A transesophageal echocardiogram did not show valvular vegetation. Colonoscopy results revealed a nonobstructing, fungating mass in the distal rectum (image A). Histologic evaluation confirmed low-grade rectal adenocarcinoma with submucosal invasion (image B). The patient was treated with 2 g of intravenous ceftriaxone daily, as the minimal inhibitory concentration to penicillin was 0.10 μg/mL. This regimen was changed to 2 g of cefazolin 3 times per week after dialysis when she was discharged to an acute rehabilitation center for a total of 4 weeks of therapy. She underwent transanal excision of her colonic mass and did not require further radiation or chemotherapy.

Patients with S gallolyticus bacteremia or endocarditis have a higher rate of colorectal cancer compared with the general population.1 Specifically, there is a higher risk for advanced adenomas and invasive carcinomas, and colonoscopy may be necessary.2


From the Department of Internal Medicine at UConn Health in Farmington, Connecticut (Drs McAuliffe and Cox), and the Department of Pathology at Hartford Hospital in Connecticut (Dr Bhat).
Financial Disclosures: None reported.
Support: None reported.

*Address correspondence to Agnes McAuliffe, DO, Department of Internal Medicine, UConn Health, 263 Farmington Ave, Farmington CT, 06030-0002. Email:


References

1. Corredoira-Sanchez J , García-GarroteF, RabuñalR, et al. Association between bacteremia due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and colorectal neoplasia: a case-control study. Clin Infect Dis. 2012;55(4):491-496. doi:10.1093/cid/cis434Search in Google Scholar PubMed

2. Corredoira JC , AlonsoMP, García-PaísMJ, et al. Is colonoscopy necessary in cases of infection by Streptococcus bovis biotype II? Eur J Clin Microbiol Infect Dis. 2014;33(2):171-177. doi:10.1007/s10096-013-1940-7Search in Google Scholar PubMed

Accepted: 2018-06-18
Published Online: 2019-01-01
Published in Print: 2019-01-01

© 2019 American Osteopathic Association

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Downloaded on 24.1.2026 from https://www.degruyterbrill.com/document/doi/10.7556/jaoa.2019.011/html
Scroll to top button